Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Kuo, Yur Ren ^a   Chen, Chien Chang ^a   Goto, Shigeru ^b   Lin, Pao Yuan ^a   Wei, Fu Chan ^a   Chen, Chao Long ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THY 1 ANTIGEN; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT;

ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHIMERA; IMMUNOMODULATION; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; GRAFT REJECTION; HUMAN; IMMUNOLOGY; MESENCHYMAL STROMA CELL; TRANSPLANTATION TOLERANCE;

GRAFT REJECTION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STROMAL CELLS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84871378660     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/854846     Document Type: Review

References (69)

1. Lee W. P. A., Composite tissue transplantation: more science and patience needed. Plastic and Reconstructive Surgery 2001 107 4 1066 1070 2-s2.0-0035313014 (Pubitemid 32233451)
2. Dubernard J. M., Devauchelle B., Face transplantation. The Lancet 2008 372 9639 603 604 2-s2.0-49649126830 10.1016/S0140-6736(08)61252-0
3. Jones J. W., Gruber S. A., Barker J. H., Breidenbach W. C., Successful hand transplantation: one-year follow-up. The New England Journal of Medicine 2000 343 7 468 473 2-s2.0-0034680052 10.1056/NEJM200008173430704 (Pubitemid 30646486)
4. Kaufman C. L., Breidenbach W., World experience after more than a decade of clinical hand transplantation: update from the Louisville hand transplant program. Hand Clinics 2011 27 4 417 421
5. Siemionow M., Ozturk C., An update on facial transplantation cases performed between 2005 and 2010. Plastic and Reconstructive Surgery 2011 128 707e 720e
6. Shores J. T., Imbriglia J. E., Lee W. P., The current state of hand transplantation. American Journal of Hand Surgery 2011 36 1862 1867
7. Lee W. P. A., Yaremchuk M. J., Pan Y. C., Randolph M. A., Tan C. M., Weiland A. J., Relative antigenicity of components of a vascularized limb allograft. Plastic and Reconstructive Surgery 1991 87 3 401 411 2-s2.0-0025971311
8. Madani H., Hettiaratchy S., Clarke A., Butler P. E. M., Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation. Journal of Plastic, Reconstructive and Aesthetic Surgery 2008 61 3 245 249 2-s2.0-38949200998 10.1016/j.bjps.2007.10.048 (Pubitemid 351215147)
9. Schneeberger S., Gorantla V. S., van Riet R. P., Lanzetta M., Vereecken P., Van Holder C., Rorive S., Remmelink M., Le Moine A., Abramowicz D., Zelger B., Kaufman C. L., Breidenbach W. C., Margreiter R., Schuind F., Atypical acute rejection after hand transplantation. American Journal of Transplantation 2008 8 3 688 696 2-s2.0-39649100164 10.1111/j.1600-6143.2007.02105.x (Pubitemid 351287537)
10. Kaufman C. L., Ouseph R., Blair B., Graft vasculopathy in clinical hand transplantation. American Journal of Transplantation 2012 12 4 1004 1016
11. Ravindra K., Haeberle M., Levin L. S., Ildstad S. T., Immunology of vascularized composite allotransplantation: a primer for hand surgeons. American Journal of Hand Surgery 2012 37 4 842 850
12. Arima N., Nakamura F., Fukunaga A., Hirata H., MacHida H., Kouno S., Ohgushi H., Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study. Cytotherapy 2010 12 2 265 268 2-s2.0-77749289235 10.3109/14653240903390795
13. Bacigalupo A., Management of acute graft-versus-host disease. British Journal of Haematology 2007 137 2 87 98 2-s2.0-33947546893 10.1111/j.1365-2141. 2007.06533.x (Pubitemid 46474711)
14. Dryden G. W. Jr., Overview of biologic therapy for Crohn's disease. Expert Opinion on Biological Therapy 2009 9 8 967 974 2-s2.0-67650663268 10.1517/14712590903048909
15. Dalal J., Gandy K., Domen J., Role of mesenchymal stem cell therapy in Crohn's disease. Pediatric Research 2012 71 4 445 451
16. Lanzoni G., Roda G., Belluzi A., Roda E., Bagnara G. P., Inflammatory bowel disease: moving toward a stem cell-based therapy. World Journal of Gastroenterology 2008 14 29 4616 4626 2-s2.0-58149196445 10.3748/wjg.14.4616
17. Connick P., Kolappan M., Crawley C., Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. The Lancet Neurology 2012 11 2 150 156
18. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J. M., Kassis I., Bulte J. W. M., Petrou P., Ben-Hur T., Abramsky O., Slavin S., Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Archives of Neurology 2010 67 10 1187 1194 2-s2.0-77957964299 10.1001/archneurol.2010.248
19. Liang J., Zhang H., Hua B., Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Annals of the Rheumatic Diseases 2010 69 8 1423 1429 2-s2.0-78650637209 10.1136/ard.2009.123463corr1
20. Shi D., Wang D., Li X., Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus. Clinical Rheumatology 2012 31 5 841 846
21. Friedenstein A. J., Gorskaja U. F., Kulagina N. N., Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology 1976 4 5 267 274 2-s2.0-0017119380
22. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 5411 143 147 2-s2.0-0033515827 10.1126/science.284.5411.143 (Pubitemid 29282067)
23. Kuo Y. R., Wang C. T., Cheng J. T., Wang F. S., Chiang Y. C., Wang C. J., Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. Plastic and Reconstructive Surgery 2011 128 4 872 880
24. Crisan M., Yap S., Casteilla L., Chen C. W., Corselli M., Park T. S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P. N., Traas J., Schugar R., Deasy B. M., Badylak S., Buhring H. J., Giacobino J. P., Lazzari L., Huard J., Péault B., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008 3 3 301 313 2-s2.0-50849139576 10.1016/j.stem.2008.07.003
25. Caplan A. I., Mesenchymal stem cells. Journal of Orthopaedic Research 1991 9 5 641 650 2-s2.0-0026228558
26. In't Anker P. S., Scherjon S. A., Kleijburg-van der Keur C., De Groot-Swings G. M. J. S., Claas F. H. J., Fibbe W. E., Kanhai H. H. H., Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004 22 7 1338 1345 2-s2.0-10444275247 10.1634/stemcells. 2004-0058 (Pubitemid 39636409)
27. Bieback K., Kern S., Klüter H., Eichler H., Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004 22 4 625 634 2-s2.0-3543003475 (Pubitemid 39014578)
28. Zuk P. A., Zhu M., Mizuno H., Huang J., Futrell J. W., Katz A. J., Benhaim P., Lorenz H. P., Hedrick M. H., Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 2001 7 2 211 228 2-s2.0-0035067539 10.1089/107632701300062859 (Pubitemid 32295155)
29. Deans R. J., Moseley A. B., Mesenchymal stem cells: biology and potential clinical uses. Experimental Hematology 2000 28 8 875 884 2-s2.0-0033824164 10.1016/S0301-472X(00)00482-3
30. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003 101 9 3722 3729 2-s2.0-0038204193 10.1182/blood-2002-07-2104 (Pubitemid 36857965)
31. Glennie S., Soeiro I., Dyson P. J., Lam E. W. F., Dazzi F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005 105 7 2821 2827 2-s2.0-15944376184 10.1182/blood-2004-09-3696 (Pubitemid 40446275)
32. Rasmusson I., Ringdén O., Sundberg B., Le Blanc K., Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003 76 8 1208 1213 2-s2.0-0242300602 10.1097/01.TP.0000082540.43730.80 (Pubitemid 37339646)
33. Nicola M. D., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., Grisanti S., Gianni A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 10 3838 3843 2-s2.0-0037093058 10.1182/blood.V99.10.3838 (Pubitemid 34534559)
34. Kuo Y. R., Chen C. C., Goto S., Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plastic and Reconstructive Surgery 2011 128 6 661e 672e
35. Kuo Y. R., Chen C. C., Shih H. S., Goto S., Huang C. W., Wang C. T., Chen C. L., Wei F. C., Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plastic and Reconstructive Surgery 2011 127 2 569 579 2-s2.0-79951618610 10.1097/PRS.0b013e318200a92c
36. Coffer P. J., Burgering B. M. T., Forkhead-box transcription factors and their role in the immune system. Nature Reviews Immunology 2004 4 11 889 899 2-s2.0-8544265317 10.1038/nri1488 (Pubitemid 39490764)
37. von Boehmer H., Mechanisms of suppression by suppressor T cells. Nature Immunology 2005 6 4 338 344 2-s2.0-16844362608 10.1038/ni1180 (Pubitemid 41716770)
38. Sakaguchi S., Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004 22 531 562 2-s2.0-2442484053 10.1146/annurev.immunol.21.120601. 141122 (Pubitemid 38680433)
39. Fehérvári Z., Sakaguchi S., Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. International Immunology 2004 16 12 1769 1780 2-s2.0-10844252294 10.1093/intimm/dxh178 (Pubitemid 40003865)
40. Nauta A. J., Fibbe W. E., Immunomodulatory properties of mesenchymal stromal cells. Blood 2007 110 10 3499 3506 2-s2.0-36348977575 10.1182/blood-2007-02-069716 (Pubitemid 350159613)
41. Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R. G., Kobayashi N., Yarmush M. L., Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplantation 2010 19 6-7 667 679 2-s2.0-77958572322 10.3727/096368910X508762
42. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 4 1815 1822 2-s2.0-13544249606 10.1182/blood-2004-04-1559 (Pubitemid 40223708)
43. Kim Y. H., Wee Y. M., Choi M. Y., Lim D. G., Kim S. C., Han D. J., Interleukin (IL)-10 induced by CD11b+ cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts. Molecular Medicine 2011 17 7-8 697 708 2-s2.0-79960701128 10.2119/molmed.2010.00098
44. English K., Ryan J. M., Tobin L., Murphy M. J., Barry F. P., Mahon B. P., Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clinical and Experimental Immunology 2009 156 1 149 160 2-s2.0-61849123247 10.1111/j.1365-2249.2009.03874.x
45. Hainz U., Jürgens B., Heitger A., The role of indoleamine 2,3-dioxygenase in transplantation. Transplant International 2007 20 2 118 127 2-s2.0-33846278407 10.1111/j.1432-2277.2006.00370.x (Pubitemid 46121989)
46. Meisel R., Zibert A., Laryea M., Göbel U., Däubener W., Dilloo D., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004 103 12 4619 4621 2-s2.0-2942595706 10.1182/blood-2003-11-3909 (Pubitemid 38745993)
47. Maccario R., Moretta A., Cometa A., Montagna D., Comoli P., Locatelli F., Podestà M., Frassoni F., Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. Biology of Blood and Marrow Transplantation 2005 11 12 1031 1032 2-s2.0-28744436422 10.1016/j.bbmt.2005.08. 039 (Pubitemid 41754722)
48. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J., Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005 105 5 2214 2219 2-s2.0-14944339174 10.1182/blood-2004-07-2921 (Pubitemid 40731815)
49. Thomson A. W., Tolerogenic dendritic cells: all present and correct? American Journal of Transplantation 2010 10 2 214 219 2-s2.0-75149155635 10.1111/j.1600-6143.2009.02955.x
50. Coates P. T. H., Colvin B. L., Kaneko K., Taner T., Thomson A. W., Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity. Transplantation 2003 75 9, supplement 32S 36S 2-s2.0-0037846483 (Pubitemid 36593081)
51. Jung Y. J., Ju S. Y., Yoo E. S., Cho S. J., Cho K. A., Woo S. Y., Seoh J. Y., Park J. W., Han H. S., Ryu K. H., MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DC. Cytotherapy 2007 9 5 451 458 2-s2.0-34548573096 10.1080/14653240701452057 (Pubitemid 47386682)
52. Morel P. A., Feili-Hariri M., Coates P. T., Thomson A. W., Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clinical and Experimental Immunology 2003 133 1 1 10 2-s2.0-0038047128 10.1046/j.1365-2249. 2003.02161.x (Pubitemid 36791935)
53. Kuo Y. R., Huang C. W., Goto S., Wang C. T., Hsu L. W., Lin Y. C., Yang K. D., Chen C. L., Lee W. P. A., Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. Journal of Surgical Research 2009 153 2 317 325 2-s2.0-67349216663 10.1016/j.jss.2008.05.034
54. Fibbe W. E., Nauta A. J., Roelofs H., Modulation of immune responses by mesenchymal stem cells. Annals of the New York Academy of Sciences 2007 1106 272 278 2-s2.0-34548401289 10.1196/annals.1392.025 (Pubitemid 47443061)
55. Jiang X. X., Zhang Y., Liu B., Zhang S. X., Wu Y., Yu X. D., Mao N., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005 105 10 4120 4126 2-s2.0-18544371666 10.1182/blood-2004-02-0586 (Pubitemid 40656164)
56. Yañez R., Lamana M. L., García-Castro J., Colmenero I., Ramírez M., Bueren J. A., Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006 24 11 2582 2591 2-s2.0-33750559121 10.1634/stemcells.2006-0228 (Pubitemid 44674320)
57. Ringdén O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lönnies H., Marschall H. U., Dlugosz A., Szakos A., Hassan Z., Omazic B., Aschan J., Barkholt L., Le Blanc K., Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006 81 10 1390 1397 2-s2.0-33744913533 10.1097/01.tp.0000214462.63943.14 (Pubitemid 43847148)
58. English K., French A., Wood K. J., Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 2010 7 4 431 442 2-s2.0-77957338676 10.1016/j.stem.2010.09.009
59. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology 2002 30 1 42 48 2-s2.0-0036142769 10.1016/S0301-472X(01)00769-X (Pubitemid 34059216)
60. Sbano P., Cuccia A., Mazzanti B., Urbani S., Giusti B., Lapini I., Rossi L., Abbate R., Marseglia G., Nannetti G., Torricelli F., Miracco C., Bosi A., Fimiani M., Saccardi R., Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Archives of Dermatological Research 2008 300 3 115 124 2-s2.0-39949084861 10.1007/s00403-007-0827-9
61. Pan H., Zhao K., Wang L., Zheng Y., Zhang G., Mai H., Han Y., Yang L., Guo S., Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Journal of Surgical Research 2010 160 2 315 324 2-s2.0-77950918454 10.1016/j.jss.2008. 09.027
62. Kuo Y. R., Sacks J. M., Lee W. P. A., Wu W. S., Kueh N. S., Yao S. F., Chiang Y. C., Porcine heterotopic composite tissue allograft transplantation using a large animal model for preclinical studies. Chang Gung Medical Journal 2006 29 3 268 274 2-s2.0-33746492224 (Pubitemid 44140238)
63. Kuo Y. R., Goto S., Shih H. S., Wang F. S., Lin C. C., Wang C. T., Huang E. Y., Chen C. L., Wei F. C., Zheng X. X., Lee W. P. A., Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 2009 87 12 1769 1777 2-s2.0-67649586583 10.1097/TP. 0b013e3181a664f1
64. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., Cavinato R. A., Todeschini M., Solini S., Sonzogni A., Perico N., Remuzzi G., Noris M., Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. The Journal of Immunology 2008 181 6 3933 3946 2-s2.0-56149110595
65. Itakura S., Asari S., Rawson J., Ito T., Todorov I., Liu C. P., Sasaki N., Kandeel F., Mullen Y., Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. American Journal of Transplantation 2007 7 2 336 346 2-s2.0-33846217749 10.1111/j.1600-6143.2006.01643.x (Pubitemid 46096326)
66. Kuo Y. R., Chen C. C., Goto S., Immunomodulatory effects of bone marrow-derived mesenchymal stem cells in a Swine hemi-facial allotransplantation model. PLoS One 2012 7 4 e35459
67. Ge W., Jiang J., Baroja M. L., Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. American Journal of Transplantation 2009 9 8 1760 1772
68. Kuo Y. R., Shih H. S., Lin C. C., Huang C. C., Yang J. C. S., Wu W. S., Goto S., Chen C. L., Lee W. P. A., Swine hemi-facial composite tissue allotransplantation: a model to study immune rejection. Journal of Surgical Research 2009 153 2 268 273 2-s2.0-64849098644 10.1016/j.jss.2008.03.050
69. Prevosto C., Zancolli M., Canevali P., Zocchi M. R., Poggi A., Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007 92 7 881 888 2-s2.0-34548739534 10.3324/haematol.11240 (Pubitemid 350144234)